No active 13F manager changed its position in AERG last quarter. Over the last 180 days, 2 insiders sold and none bought, a net -$60K in open-market trades.
The legs disagree, or only one of them leans.
1 tracked 13F filer discloses a position in AERG as of the latest SEC 13F filings, a combined $134 in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Game Plan Financial Advisors, LLC | 100 | $134 | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 8, 2026 | Adamczyk Bradford Thomas | Director | Sell (S) | 10K | $15K |
| Jun 1, 2026 | Donaghey Christopher Wayne | President & CEO, Director | Sell (S) | 10K | $15K |
| May 11, 2026 | Adamczyk Bradford Thomas | Director | Sell (S) | 10K | $15K |
| May 11, 2026 | Donaghey Christopher Wayne | President & CEO, Director | Sell (S) | 10K | $15K |
| Jan 26, 2026 | Donaghey Christopher Wayne | President & CEO/Principal AO, Director | Sell (S) | 10K | $17K |
| Jan 21, 2026 | Quarles Gregory James | CEO Emeritus, Director | Sell (S) | 7K | $12K |
| Jan 20, 2026 | McCahon Stephen William | Chief Science Officer | Sell (S) | 10K | $18K |
| Jan 7, 2026 | Adamczyk Bradford Thomas | Director | Sell (S) | 10K | $18K |
| Dec 29, 2025 | Donaghey Christopher Wayne | President & CEO/Principal AO, Director | Sell (S) | 8K | $15K |
| Dec 26, 2025 | Donaghey Christopher Wayne | President & CEO/Principal AO, Director | Sell (S) | 2K | $4K |
| Dec 22, 2025 | Quarles Gregory James | CEO Emeritus, Director | Sell (S) | 10K | $19K |
| Dec 22, 2025 | McCahon Stephen William | Chief Science Officer | Sell (S) | 10K | $19K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 0 | 0 | – |
Insiders Form 4 open-market | 0 | 2 | -$60K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for AERG
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/AERG/capital-change-brief"
Use Arkolith's capital_change_brief for AERG. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for AERG. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.